| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/09/2008 | CN101157674A Method for purifying citalopram salt |
| 04/09/2008 | CN101157673A Maleic anhydride production technique |
| 04/09/2008 | CN101157048A A high performance vanadium phosphorus oxygen catalyst with nanostructure as well as its preparing method |
| 04/08/2008 | US7355049 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/08/2008 | CA2203183C Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008037628A1 Sulfonamide derivatives |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | WO2008005955A9 Synthesis of heterocyclic compounds |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080081293 Gives patterns having high resolution, high sensitivity and good exposure margin; fine processing of semiconductors |
| 04/03/2008 | DE102007005606A1 Preparing catalyst molded body comprises adding a finely ground precursor mixture to the graphite until the desired geometry is formed, thermally treating the catalyst precursor molded body to obtain the catalyst molded body |
| 04/03/2008 | CA2664037A1 Sulfonamide derivatives |
| 04/02/2008 | EP1905760A1 Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate |
| 04/02/2008 | EP1905438A2 Hypoglycemic agent |
| 04/02/2008 | EP1904537A1 Polymerisation catalyst system based on dioxime ligands |
| 04/02/2008 | EP1904469A1 New pyrocatechin derivatives |
| 04/02/2008 | EP1904443A1 New benzoheterocyclylethylbenzamide derivatives |
| 04/02/2008 | EP1729759A4 Salvinorin derivatives and uses thereof |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101153036A Organic light-emitting compound and organic light-emitting element comprising the same |
| 04/02/2008 | CN101153030A Polysubstitution hydrogenated naphthalene compounds, producing method and uses of the same |
| 04/02/2008 | CN101153029A Method for purifying fluorocarbon solvent |
| 04/02/2008 | CN101152227A Effective component of ligusticum wallichii, preparing method and application of the same |
| 04/02/2008 | CN100378088C Preparation method of red sage root total phenolic acid |
| 04/02/2008 | CN100378087C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/01/2008 | US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents |
| 04/01/2008 | US7351843 [5-(2-fluorophenyl)furan-2-ylcarbonyl]guanidine; (sodium-hydrogen exchanger isoform 1 (NHE-1) inhibitor; ischemia/reperfusion, myocardial infarction, arrhythmia, angina pectoris |
| 04/01/2008 | US7351842 Compounds for treatment of cardiac arrhythmia and methods of use |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 04/01/2008 | US7351734 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | US7351311 Water-containing tetrahydrofuran is purified by passing through three distillation columns, withdrawing water from first column, recycling water-containing tetrahydrofuran from top of second column into the first column, passing a sidestream of the first column into second column, recycling the |
| 03/27/2008 | WO2008036653A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
| 03/27/2008 | WO2007109334B1 Sip receptor modulating compounds and use thereof |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076188 Luminescent compounds |
| 03/27/2008 | US20080076063 Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same |
| 03/27/2008 | CA2662773A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1903030A1 Method for catalytic manufacture of aromatic or heteroaromatic nitriles |
| 03/26/2008 | EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 03/26/2008 | EP1902017A1 Antiviral compounds and methods |
| 03/26/2008 | EP1901843A1 Method for start-up of oxidation catalysts |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN101151248A 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/26/2008 | CN101148654A Method for separating and purifying bi(5-formylfurfuryl)ether |
| 03/26/2008 | CN101148442A Histone deacetylase inhibitor and its preparation method and use |
| 03/26/2008 | CN101148441A Andrographolidi natrii bisulfis and preparation method thereof |
| 03/26/2008 | CN100376563C Novel purpose of 4-(4-methyl-3-pentenyl)-4-cyclohexene-1, 2-diacid anhydride |
| 03/26/2008 | CN100376562C Production of furanones |
| 03/26/2008 | CN100376560C New tricyclic compounds and their use as medicine, process for their preparation and pharmaceutical compositions containing them |
| 03/26/2008 | CN100376551C Semicarbazone synthesis method |
| 03/25/2008 | USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 03/25/2008 | US7348442 Reacting a lactone with formaldehyde, using a hydrotalcite catalyst of carbonates of Magnesium,and one of Zinc, Nickel, Cobalt, Iron, and Copper; and aluminum hydroxide and one of Iron or chromium; superior hydrothermal stability |
| 03/25/2008 | US7348428 Triarylamine containing monomers for optoelectronic devices |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348358 Use of cyclolignans |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348290 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same |
| 03/20/2008 | WO2008032702A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same |
| 03/20/2008 | WO2008032171A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | WO2008032156A1 Diaryl ether derivatives and uses thereof |
| 03/20/2008 | WO2008031811A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | WO2008031534A1 Insecticidal compounds |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2008008954A3 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | US20080071098 Hydrogenation of esters with ru/tetradentate ligands complexes |
| 03/20/2008 | US20080071084 Method for preparing alkyl ethers and aryl ethers |
| 03/20/2008 | US20080070970 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 03/20/2008 | US20080070956 ATPase inhibitors; Substituted fluorene or benzenerings joined to an alkylene through a sulfone or sulfoxide linkage; without excessive toxicity, irritation, allergic response etc.; sleep dioredrs like excessive sleepiness; Parkinson's disease; Alzheimer's disease; ADD; ADHA; depression, fatigue |
| 03/20/2008 | US20080070910 aromatic or heterocyclic/heterobicyclic carbamate compounds as protease inhibitors , useful for inhibiting the development of drug resistance of HIV in HIV infected animals; improved pharmacokinetics; protease inhibitors |
| 03/20/2008 | US20080070887 Diaryl Ether Derivatives and Uses Thereof |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080067123 carbon surfaces such as carbon black, fullerenes, graphite, and activated carbon are modified by reacting with a reactant having at least one double bond and one or more electron withdrawing groups, e.g. maleic anhydride; reactive carbon surface can be further functionalized by nucleophilic groups |
| 03/20/2008 | DE102006039912A1 Substituierte Spirotetronsäuren und ihre Verwendung Substituted Spirotetronsäuren and their use |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663178A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | CA2663129A1 Nitrate esters of aminoalcohols |
| 03/19/2008 | EP1900720A1 Process for production of substituted cyclopentanone |
| 03/19/2008 | EP1900367A2 Hypoglycemic agent |
| 03/19/2008 | EP1900366A2 Hypoglycemic agent |
| 03/19/2008 | EP1899315A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators |
| 03/19/2008 | EP1899314A2 High yield synthesis methods for producing organic salts of strontium |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | EP1797061B1 Method for the distillative processing of tetrahydrofuran |
| 03/19/2008 | EP1532130A4 Process for the production of an immunosuppressant |
| 03/19/2008 | EP1296970B1 Method for the preparation of citalopram |
| 03/19/2008 | EP1219657B1 Polyarylene and method for production thereof |